BIOSTAR PHARM-B (02563) announced that on May 6, 2026, the board of directors resolved to adopt a share option plan pursuant to Chapter 17 of the Listing Rules. The plan is intended to provide incentives or rewards to participants in recognition of their contributions or potential contributions to the Group's growth and development.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments